tiprankstipranks
Advertisement
Advertisement

LGN Stock Latest News

Legence 13.4M share Secondary priced at $54.00
The FlyLegence 13.4M share Secondary priced at $54.00
3d ago
LGN
Morning Movers: Soleno pops, Neurocrine dips after acquisition agreement
PremiumThe Fly
Morning Movers: Soleno pops, Neurocrine dips after acquisition agreement
5d ago
DOW
LGN
Legence files to sell 11M shares of Class A common stock for holders
PremiumThe Fly
Legence files to sell 11M shares of Class A common stock for holders
5d ago
BX
LGN
Legence files to sell 11M shares of Class A common stock for holders
PremiumThe Fly
Legence files to sell 11M shares of Class A common stock for holders
5d ago
LGN
Legence price target raised to $60 from $58 at Stifel
PremiumThe Fly
Legence price target raised to $60 from $58 at Stifel
11d ago
LGN
Legence price target raised to $62 from $55 at BofA
PremiumThe FlyLegence price target raised to $62 from $55 at BofA
12d ago
LGN
Legence price target raised to $64 from $48 at RBC Capital
Premium
The Fly
Legence price target raised to $64 from $48 at RBC Capital
12d ago
LGN
Legence price target raised to $63 from $46 at BMO Capital
Premium
The Fly
Legence price target raised to $63 from $46 at BMO Capital
12d ago
LGN
Legence price target raised to $74 from $68 at Guggenheim
PremiumThe Fly
Legence price target raised to $74 from $68 at Guggenheim
12d ago
LGN
Legence price target raised to $63 from $52 at Goldman Sachs
PremiumThe Fly
Legence price target raised to $63 from $52 at Goldman Sachs
12d ago
LGN
Legence Corp. Delivers Record Results, Lifts 2026 Outlook
PremiumCompany Announcements
Legence Corp. Delivers Record Results, Lifts 2026 Outlook
13d ago
LGN
Tigress Financial sees AI momentum powering gowth for Legence
PremiumThe Fly
Tigress Financial sees AI momentum powering gowth for Legence
14d ago
LGN
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
PremiumThe FlyMidday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
15d ago
U
CG
Morning Movers: AstraZeneca jumps following tozorakimab trial results
Premium
The Fly
Morning Movers: AstraZeneca jumps following tozorakimab trial results
15d ago
AGX
AZN
Legence reports Q4 EPS (55c), consensus 5c
Premium
The Fly
Legence reports Q4 EPS (55c), consensus 5c
15d ago
LGN
Options Volatility and Implied Earnings Moves Today, March 27, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 27, 2026
15d ago
CCL
LGN
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
16d ago
CCL
LGN
Legence price target raised to $68 from $53 at Guggenheim
PremiumThe Fly
Legence price target raised to $68 from $53 at Guggenheim
16d ago
LGN
LGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LGN Earnings this Week: How Will it Perform?
17d ago
LGN
Legence Corp. Class A: Levered to Structural Pharma Reshoring and Data Center Capex Upswings, Justifying a Buy Rating
PremiumRatingsLegence Corp. Class A: Levered to Structural Pharma Reshoring and Data Center Capex Upswings, Justifying a Buy Rating
2M ago
LGN
Legence price target raised to $52 from $46 at Goldman Sachs
Premium
The Fly
Legence price target raised to $52 from $46 at Goldman Sachs
2M ago
LGN
Legence price target raised to $58 from $50 at Stifel
Premium
The Fly
Legence price target raised to $58 from $50 at Stifel
2M ago
LGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >